The roles of osteoprotegerin in bone diseases: a brief review

Articles in Press

Document Type : Systematic Review

Authors
M. mohammadi
A. jalali
Sport Medicine and Knee Research Center, Milad Hospital, Tehran, Iran.
10.48311/ijmpp.2025.110577.0
Abstract
Aim: This article aims to highlight the crucial role of Osteoprotegerin (OPG) in bone homeostasis and to propose it as a potential therapeutic target for common bone diseases.
Method and Materials: A literature review was conducted focusing on the structure, function, and regulatory effects of OPG on osteoclast activity, as well as its mechanism as a decoy receptor that inhibits osteoclast formation.
Findings: Evidence indicates that OPG plays a protective role against excessive bone loss by inhibiting osteoclast differentiation and activity. Its unique structure, consisting of a signal peptide and seven functional domains, enables it to act effectively in the extracellular space to maintain bone balance.
Conclusion: OPG is a key regulator of bone metabolism and may represent a promising therapeutic target for the treatment and prevention of bone-related disorders. Increased attention to this protein could lead to innovative therapeutic strategies in metabolic bone disease management.

 

Keywords

Subjects

International Journal of Musculoskeletal Pain Prevention

Articles in Press, Accepted Manuscript
Available Online from 15 October 2025